Sangamo Therapeutics SGMOQ
OTC SGMOQ
$0.15 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Sangamo Therapeutics (SGMOQ) Other Non Operating Income (2024 - 2025)

Updated

Sangamo Therapeutics (SGMOQ) recorded Other Non Operating Income of -$21,000 in Q4 2025, compared with $1.87 million a year earlier.

Analysis

Sangamo Therapeutics (SGMOQ) Other Non Operating Income (2024 - 2025) Analysis & Trends

For FY2025, Sangamo Therapeutics reported Other Non Operating Income of -$3.56 million.

  • Across earlier years, Other Non Operating Income came in at $4.35 million in FY2024.
  • Quarterly Other Non Operating Income has ranged from -$2.49 million in Q2 2025 to $2.08 million in Q1 2024 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $107,000 (Q3 2025), -$2.49 million (Q2 2025) and -$1.16 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Sangamo Therapeutics 42.03 Mn -72.08 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -21,000.00
Sep 30, 2025 107,000.00
Jun 30, 2025 -2.49 Mn
Mar 31, 2025 -1.16 Mn
Dec 31, 2024 1.87 Mn
Sep 30, 2024 -221,000.00
Jun 30, 2024 614,000.00
Mar 31, 2024 2.08 Mn
API Access

Sangamo Therapeutics Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY